about
In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanomaCoding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAsThe collagen chaperone HSP47 is a new interactor of APP that affects the levels of extracellular beta-amyloid peptidesFunctional annotation and identification of candidate disease genes by computational analysis of normal tissue gene expression data.Prediction of human disease genes by human-mouse conserved coexpression analysis.Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion.Synaptic Interactome Mining Reveals p140Cap as a New Hub for PSD Proteins Involved in Psychiatric and Neurological Disorders.Evaluation of candidate genes from orphan FEB and GEFS+ loci by analysis of human brain gene expression atlasesThe MeCP2/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesis.Candidate gene prioritization based on spatially mapped gene expression: an application to XLMRThe BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo.Drug repositioning for orphan genetic diseases through Conserved Anticoexpressed Gene Clusters (CAGCs)SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma.Hypomethylation of smoking-related genes is associated with future lung cancer in four prospective cohortsCombined CSL and p53 downregulation promotes cancer-associated fibroblast activationHepatocyte Growth Factor-mediated satellite cells niche perturbation promotes development of distinct sarcoma subtypes.Integrated transcriptional and competitive endogenous RNA networks are cross-regulated in permissive molecular environmentsMicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling.Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in RhabdomyosarcomaCopy number variants analysis in a cohort of isolated and syndromic developmental delay/intellectual disability reveals novel genomic disorders, position effects and candidate disease genes.Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis.An exclusive cellular and molecular network governs intestinal smooth muscle cell differentiation in vertebrates.Characterization and analysis of the composition and dynamics of the mammalian riboproteome.Failure to downregulate the BAF53a subunit of the SWI/SNF chromatin remodeling complex contributes to the differentiation block in rhabdomyosarcoma.A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer.Bone marrow endosteal mesenchymal progenitors depend on HIF factors for maintenance and regulation of hematopoiesis.DNA methylation changes measured in pre-diagnostic peripheral blood samples are associated with smoking and lung cancer risk.Citron Kinase Deficiency Leads to Chromosomal Instability and TP53-Sensitive Microcephaly.A PML–PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance.Rictor/mTORC2 deficiency enhances keratinocyte stress tolerance via mitohormesis.Evolution of promoter affinity for transcription factors in the human lineage.Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2α Scaffolding Function.Increasing Agrin Function Antagonizes Muscle Atrophy and Motor Impairment in Spinal Muscular Atrophy.Corrigendum: Combined CSL and p53 downregulation promotes cancer-associated fibroblast activationPseudogenes as competitive endogenous RNAs: target prediction and validationProteomics-Based Evidence for a Pro-Oncogenic Role of ESRP1 in Human Colorectal Cancer Cells
P50
Q24629400-610B0A5B-EE46-4FAE-98FE-A2F8614CA4C7Q24629589-92E36ED5-0E22-4BCE-93F8-3D96E3118E03Q28476363-D776BA8A-6BD6-403B-9984-199B87B6424AQ31159561-375AB49C-6091-467F-B5FE-13705AE1845DQ33325895-018962DE-9AAC-4935-B039-AC9B8394B838Q33677421-DF01D579-9548-4428-9D35-A604F82AF076Q33856549-8FB18B07-C357-4D4B-A3C5-4FDEDC58B596Q33999205-F762AB04-B36F-4E46-ABB5-0D83A3DF797EQ34013518-BBEAF8B1-E72C-4129-BD7E-85AAFDF52981Q34110458-82C49963-D662-4CC5-BBE6-8FC634174486Q34470339-1258230F-BA50-4E33-99B1-3C2A98E387F9Q35006731-D0038297-6C28-4910-8175-83F27E768FA4Q36186504-42A72915-7986-4F69-BA9A-419F5B0C6425Q36379584-8E8633B4-8D6C-458D-BFD6-3E99BCB6A94AQ36425130-01734BFB-85D7-4846-A4DA-4E8E0E1FF2E5Q36739725-EDFA1628-F0C9-45EF-9390-269241D2F93CQ36820041-93436CC5-E40C-4803-9CAA-BFD8087C8FA3Q37156452-23A37CEE-23AB-4AD1-AE12-670508B96F08Q38749559-D8AC6E55-915D-4211-82DA-B155226C0AF5Q38907089-D6B4A334-CFA2-4B51-ADBF-D162B65B3815Q38912800-650CEE97-0FD6-45BE-9F3B-9BA7CDD8F0CEQ39042242-3EBC7067-9D3F-4C1B-8444-1F59AA5D5CD3Q39093565-89C8428D-45E8-4337-B2DD-0B1A443F1B40Q39144774-A93DCA67-94BA-4B0B-889F-0487A53A8753Q39144862-7B723063-2EAB-4E98-8B81-4675B4F9E674Q40472737-C6801485-381B-4041-A967-AD536B6DF103Q40579950-45F78B05-2075-4312-99A8-52A029A10E46Q41915817-E864CB95-4278-4214-B5D8-C924C85078AAQ43195305-D5298C79-5803-4F88-9F97-D0F2EE31088DQ46416340-5E7B72CA-647A-4FD1-B44F-E1F0D891EDADQ46599202-91E122BA-7496-4878-918A-168487DD5F01Q47583505-35A7F765-78D0-4675-AB8B-78A4B29D636DQ49304342-95AA4D77-4C28-4E00-B2BF-0ED9AE90E27FQ86319992-99155FD1-89B4-48A5-BA88-A24CA49C872DQ87866966-27F894B0-C068-47AE-B21B-53E0DE8D13F1Q92808657-5AE64C5B-D269-42DC-83C2-FF7B41A8E0A8
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ugo Ala
@ast
Ugo Ala
@en
Ugo Ala
@es
Ugo Ala
@sl
type
label
Ugo Ala
@ast
Ugo Ala
@en
Ugo Ala
@es
Ugo Ala
@sl
prefLabel
Ugo Ala
@ast
Ugo Ala
@en
Ugo Ala
@es
Ugo Ala
@sl
P1053
K-2029-2016
P106
P1153
23994859500
P21
P31
P3829
P496
0000-0001-5408-6397